Covance Not Cooling...
Health Care: Health Services
Thoratec Corporation (THOR: NASDAQ)
$32.60 -0.63 | -1.90%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 32.60 |
| 52 Week High | 39.86 |
| 52 Week Low | 29.39 |
| Avg. Daily Vol. (Mil) | 0.63 |
| Beta (3 year) | 0.78 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,868.97 |
| Shares Out (Mil) | 57.33 |
| Float (Mil) | 57.16 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.30 |
| Current Ratio | 6.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | 39.30 |
| Price/Sales | 3.87 |
| Price/Book | 3.03 |
| Price/Cash Flow | 26.40 |
| Per Share Data | |
| Earnings | 0.83 |
| Sales | 8.42 |
| Book Value | 10.77 |
| Cash Flow | 1.23 |
| Business Summary | |
|---|---|
| Thoratec Corporation develops, manufactures and markets proprietary medical devices used for circulatory support. | |
| General Information | |
| 6035 Stoneridge Drive
Pleasanton, CA 94588 |
|
| www.thoratec.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 855 | |
| CEO: Mr. Gerhard F. Burbach | |
| Short Interest | |
| Current Month (Mil) | 2.46 |
| Previous Month (Mil) | 2.94 |
| Short Interest Ratio (Days) | 5.10 |
| Management Effectiveness | |
| Return on Equity | 7.90 |
| Return on Assets | 6.90 |
| Return on Investments | 7.90 |
| Profitability | |
| Gross Margin | 63.80 |
| EBIT Margin | 13.30 |
| Profit Margin | 10.10 |
Portfolios with THOR
- Portfolio NameUser Type
- Usermy portfolio
- ContributorStocks Rising On Unusual Vo...
- ContributorMost-Searched Stocks for th...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Health Care Stocks With ...
- UserAberian System, MEDICAL stocks
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Best-Rate...
- UserJust Lookin'
- UserPART 5 JPMorgan 28th Annual...
Latest THOR Headlines from TheStreet
- THOR Makes Notable Cross Below Critical Moving Average 04.18.13 | 11:04 am
- 8 Stocks Climbing Higher on Unusual Volume 11.21.12 | 02:11 pm
- Sunshine Heart: A Promising Treatment for Heart Failure Patients 11.05.12 | 08:11 am
- Analysts' Actions: TXN HAL DFS CELG THOR 10.03.12 | 10:10 am
- Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 11:08 pm
- Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 11:05 pm
- 7 Hot Stocks on Traders' Radars 04.05.12 | 11:04 am
- Analysts' Actions: CSCO, MMM, CIT, AMGN, S 02.09.12 | 09:02 am
- Thoratec Stock Gaps Up On Today's Open (THOR) 02.09.12 | 08:02 am
- Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.08.12 | 07:02 pm
Press Releases for THOR
- Thoratec Presentation At Bank Of America Merrill Lynch 2013 Health Care Conference To Be Webcast - PR Newswire 05.14.13 | 09:05 am
- Thoratec Schedules First Quarter Conference Call, Webcast - PR Newswire 04.22.13 | 03:04 pm
- Meet Ms. Joe Ann Bivins, The World's Longest-Supported Recipient Of A Single Heart Assist Device - PR Newswire 03.19.13 | 09:03 am
- Thoratec Announces The First Human Use Of HeartMate PHPâ¿¢ - PR Newswire 03.18.13 | 08:03 am
- Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast - PR Newswire 03.11.13 | 04:03 pm
- Thoratec Presentation At Leerink Swann Global Healthcare Conference To Be Webcast - PR Newswire 02.11.13 | 08:02 am
- Thoratec Schedules Fourth Quarter Conference Call, Webcast - PR Newswire 01.28.13 | 09:01 am
- Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II® - PR Newswire 01.07.13 | 08:01 am
- Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast - PR Newswire 01.03.13 | 08:01 am
- Thoratec Announces Approval For HeartMate II® In Japan - PR Newswire 12.11.12 | 08:12 am
Partner Headlines for THOR
- Bull of the Day: Thoratec Corp. (THOR) - Bull of the Day - Zacks 12.07.12 | 01:12 am
- Stocks Hold Modest Gains; Stratasys Breaks Out - Investor's Business Daily 11.21.12 | 01:11 pm
- Thoratec Achieves 52-Week High - Analyst Blog - Zacks 11.05.12 | 06:11 pm
- Heart Failure: 'New Epidemic' Creates New Opportunities For Investors - Seeking Alpha 11.04.12 | 08:11 am
- Abiomed Beats 2Q Ests, Profit Jumps - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Thoratec Corporation (THOR) - Bull of the Day - Zacks 10.10.12 | 01:10 am
- FDA Approves Abiomed's Impella CP - Analyst Blog - NASDAQ 09.11.12 | 11:09 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - Zacks 09.11.12 | 07:09 pm
- 3 Healthcare Stocks With Positive Momentum - Seeking Alpha 09.01.12 | 08:09 am
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
